Form 4 filed by Gaslightwala Abizer
Gaslightwala Abizer filed this Form 4 on AKTX (Akari Therapeutics Plc) with 5 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-16 21:20:09 UTC.
- Accession
- 0001493152-26-047454
- Filer
- CIK 2049375
- Filed
- 2026-10-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: AKTX · Akari Therapeutics Plc (CIK 1541157)
- Gaslightwala Abizer director, officer (CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares | 2026-10-14 | M exercised | +19,333 | $0.0004 | 33,440 | D |
| American Depositary Shares representing Ordinary Shares | 2026-10-14 | M exercised | +7,733 | $0.0004 | 41,173 | D |
| Stock Option (Right to Buy) derivative | 2026-08-18 | A granted | +174,000 | $0 | 174,000 | D |
| Pre-Funded Warrant to Purchase ADSs derivative | 2026-10-14 | M exercised | -19,333 | $16.16 | 0 | D |
| Pre-Funded Warrant to Purchase ADSs derivative | 2026-10-14 | M exercised | -7,733 | $16.16 | 0 | D |